Publications

Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

 105
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

Tags:

Previous Article

Opposing roles for AMPK in regulating distinct mitophagy pathways

Next Article

Gene replacement therapy for hereditary spastic paraplegia type 47

Related Posts

Structural and functional mechanisms of anti-NMDAR autoimmune encephalitis

Structural and functional mechanisms of anti-NMDAR auto...

 120

Global organelle profiling reveals subcellular localization and remodeling at proteome scale

Global organelle profiling reveals subcellular localiza...

 80

Fragmented rRNAs and lineage-specific RNA-binding proteins define myzozoan mitoribosomes

Fragmented rRNAs and lineage-specific RNA-binding prote...

 54